A Phase 2 Study of Cisplatin in Patients with Hepatocellular Carcinoma
作者:
Shuichi Okada,
Nobuo Okazaki,
Haruhiko Nose,
Yasuhiro Shimada,
Masaki Yoshimori,
Kazunori Aoki,
期刊:
Oncology
(Karger Available online 1993)
卷期:
Volume 50,
issue 1
页码: 22-26
ISSN:0030-2414
年代: 1993
DOI:10.1159/000227142
出版商: S. Karger AG
关键词: Hepatocellular carcinoma;Cisplatin;Chemotherapy
数据来源: Karger
摘要:
A phase 2 study of cisplatin was performed in 28 previously untreated patients with unresectable hepatocellular carcinoma. The drug was given intravenously at a dose of 80 mg/m2 50% reduction in serum AFP levels after treatment. The current study indicates that cisplatin is an anticancer agent worthy of further testing in patients with this disease
点击下载:
PDF
(1869KB)
返 回